Takeda Pharmaceutical Co Ltd TKPHF:OTCPK

*Data is delayed | Exchange | USD
Last | 03/25/24 EDT
28.45UNCH (UNCH)
Volume
5,600
52 week range
26.25 - 34.47
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close28.45
  • 52 Week High34.47
  • 52 Week High Date05/09/23
  • 52 Week Low26.25
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap45,702.66M
  • Shares Out1,568.91M
  • 10 Day Average Volume1,054
  • Dividend1.22
  • Dividend Yield4.27%
  • Beta-
  • YTD % Change-0.97

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close28.45
  • 52 Week High34.47
  • 52 Week High Date05/09/23
  • 52 Week Low26.25
  • 52 Week Low Date10/30/23
  • Market Cap45,702.66M
  • Shares Out1,568.91M
  • 10 Day Average Volume1,054
  • Dividend1.22
  • Dividend Yield4.27%
  • Beta-
  • YTD % Change-0.97

RATIOS/PROFITABILITY

  • EPS (TTM)0.81
  • P/E (TTM)35.13
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date09/27/2018
  • Div Amount90.00
  • Split Date-
  • Split Factor-

Latest On Takeda Pharmaceutical Co Ltd

 

Profile

MORE
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric...
Masami Iijima
Chairman of Board of Directors, Independent Director
Christophe Weber
President, Chief Executive Officer, Representative Director
Costa Saroukos
Chief Financial Officer, Director
Address
4F, 2-1-1, Nihombashihon-cho
Chuo-ku, TKY
103-8668
Japan